All terms in BAO
| Label | Id | Description |
|---|---|---|
| intramuscular hemangioma | DOID_468 | |
| musculoskeletal system benign neoplasm | DOID_0060099 | [An organ system benign neoplasm that is located_in the muscular and skeletal organs.] |
| integumentary system cancer | DOID_0060122 | [An organ system cancer that is located_in the skin, hair and nails.] |
| Daphnia magna metabolite | CHEBI_83056 | |
| central nervous system stimulant | CHEBI_35337 | |
| central nervous system drug | CHEBI_35470 | |
| splenic marginal zone lymphoma | DOID_0050750 | [A marginal zone B-cell lymphocyte located_in the spleen comprised of B-cells in place of white pulp.] |
| marginal zone B-cell lymphoma | DOID_0050748 | [A B-cell lymphoma that is characterized by initial formation in the marginal zones of lymph tissue.] |
| eukaryotic initiation factor 4F inhibitor | CHEBI_137079 | |
| serotonin uptake inhibitor | CHEBI_50949 | |
| cerebellar ataxia | DOID_0050753 | [A cerebellar disease characterized by ataxia originating in the cerebellum.] |
| second generation antipsychotic | CHEBI_65191 | |
| antipsychotic agent | CHEBI_35476 | |
| H2-receptor antagonist | CHEBI_37961 | |
| ataxia with oculomotor apraxia type 2 | DOID_0050755 | |
| first generation antipsychotic | CHEBI_65190 | |
| deafness dystonia syndrome | DOID_0050757 | [A mitochondrial metabolism disease that is characterized by hearing loss that begins early in life, problems with movement, impaired vision, and behavior problems.] |
| Batten disease | DOID_0050756 | |
| myotonic dystrophy type 2 | DOID_0050759 | [A myotonic disease that is characterized by myotonia and progressive, proximal muscle wasting and weakness affecting the skeletal and smooth muscles of the neck, shoulders, elbows and hips and has_physical_basis_in the autosomal dominant inheritance of the CNBP (ZNF9) gene containing an expansion of a CCTG repeat in intron one.] |
| metabolic acidosis | DOID_0050758 | [A lactic acidosis that has_material_basis_in high levels of acid.] |